Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA31 (SNORA31) is a non-protein-coding RNA gene located on chromosome 9, responsible for guiding the modification (specifically, pseudouridylation) of ribosomal RNA nucleotides. SNORA31 belongs to the H/ACA box class of small nucleolar RNAs, which target uridine residues in substrate RNAs for conversion to pseudouridine, a process essential for the proper function and maturation of ribosomal RNA. There are currently no known direct drug interactions or major disease roles established for SNORA31, and it is not considered a canonical therapeutic target in drug development or clinical practice[9][5]. No protein product, receptor, enzyme activity, or conventional "target" functions are attributed to this locus; it operates purely at the RNA level.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA31 (SNORA31).